3 results match your criteria: "Cleveland Clinic hatipou@ccf.org.[Affiliation]"
Cleve Clin J Med
May 2020
Director, COPD Center, Respiratory Institute, Cleveland Clinic
Traditional therapies for emphysema such as bronchodilators and anti-inflammatory drugs have limited value due to permanent structural changes in the emphysematous lung that result in hyperinflation. Surgical lung volume reduction partially corrects hyperinflation by removing emphysematous lung and is an option in selected patients, but it carries a risk of morbidity and death. Valve therapy is a less-invasive option that involves bronchoscopic implantation of 1-way valves in emphysematous lung segments to allow air flow and mucus clearance in the direction of central airways.
View Article and Find Full Text PDFCleve Clin J Med
May 2020
Department of Critical Care Medicine, Respiratory Institute, Cleveland Clinic
Cleve Clin J Med
June 2014
Respiratory Institute, Cleveland Clinic; Associate Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH.
Our understanding of how to manage chronic obstructive pulmonary disease (COPD) has advanced significantly over the past decade. Physicians should instill optimism for improved symptoms and quality of life in their patients with COPD, a previously stigmatized condition.
View Article and Find Full Text PDF